C700-2602 Screening compound: 1-{4-[(4-methylphenyl)methyl]-3-oxo-3,4-dihydroquinoxalin-2-yl}-N-(2-phenylpropyl)piperidine-4-carboxamide

C700-2602 Screening compound: 1-{4-[(4-methylphenyl)methyl]-3-oxo-3,4-dihydroquinoxalin-2-yl}-N-(2-phenylpropyl)piperidine-4-carboxamide
C700-2602 Screening compound: 1-{4-[(4-methylphenyl)methyl]-3-oxo-3,4-dihydroquinoxalin-2-yl}-N-(2-phenylpropyl)piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C700-2602
1-{4-[(4-methylphenyl)methyl]-3-oxo-3,4-dihydroquinoxalin-2-yl}-N-(2-phenylpropyl)piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C700-2602

Molecular Formula

C31H34N4O2 (C31 H34 N4 O2)

Compound Name

1-{4-[(4-methylphenyl)methyl]-3-oxo-3,4-dihydroquinoxalin-2-yl}-N-(2-phenylpropyl)piperidine-4-carboxamide

IUPAC name

1-{4-[(4-methylphenyl)methyl]-3-oxo-34-dihydroquinoxalin-2-yl}-N-(2-phenylpropyl)piperidine-4-carboxamide

SMILES

CC(CNC(C(CC1)CCN1C1=Nc(cccc2)c2N(Cc2ccc(C)cc2)C1=O)=O)c1ccccc1

InChI

InChI=1S/C31H34N4O2/c1-22-12-14-24(15-13-22)21-35-28-11-7-6-10-27(28)33-29(31(35)37)34-18-16-26(17-19-34)30(36)32-20-23(2)25-8-4-3-5-9-25/h3-15,23,26H,16-21H2,1-2H3,(H,32,36)/t23-/m0/s1

InChI Key

MLRSTHXFWDKZCZ-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD26965784

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.64

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.339

Distribution Coefficient, logD

5.339

Water Solubility, LogSw

-5.23

Polar Surface Area

50.633

Acid Dissociation Constant (pKa)

14.34

Base Dissociation Constant (pKb)

3.61

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

32.30

C700-2602 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with C700-2602 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C700-2602?
Check Price and Availability of C700-2602, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C700-2602 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C700-2602
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C700-2602
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C700-2602 available by request